303975-37-3Relevant academic research and scientific papers
Azerocyclic compounds and their uses
-
, (2022/01/20)
The present invention proposes a nitrogen heterocyclic compound and its use, in particular, the present invention proposes a new compound that effectively inhibits ATX, which is a compound shown in the formula below, or a tautomer of the compound shown be
IRAK DEGRADERS AND USES THEREOF
-
Paragraph 00962; 002799; 002802-002803, (2020/06/19)
The present invention provides compounds, compositions thereof, and methods of using the same.
MERTK DEGRADERS AND USES THEREOF
-
Paragraph 00805, (2020/01/31)
The present invention provides compounds, compositions thereof, and methods of using the same.
NOVEL ADENINE COMPOUND
-
Page/Page column 62-63, (2008/12/06)
An adenine compound or its pharmaceutically acceptable salt as a medicament as shown following formula (1): wherein R1 is optionally substituted alkyl group, etc., X is oxygen atom, etc., A is 4 to 8 membered optionally substituted saturated or unsaturated heterocyclic group containing 1 to 2 hetero atoms selected from 1 to 3 nitrogen atoms, 0 to 1 oxygen atom and 0 to 1 sulfur atom, L1 and L2 are independently straight or branched chain alkylene, or a single bond, R2 is optionally substituted alkyl group, etc.
Cyclic hexapeptides having antibiotic activity
-
, (2008/06/13)
This invention relates to new polypeptide compound represented by general formula (I), wherein R1, R2, R3, R4, R5 and R6 are as defined in the description or a salt thereof which has antimicrobial activities (especially, antifungal activities), inhibitory activity on β-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal.
